Skip to main content
TipRanks
Go Ultimate75% OFF

Fermentalg SA (ALGAE) AI Stock Analysis

5 Followers
FR:ALGAE

Fermentalg SA

(Paris:ALGAE)

Select Model
Rating:44Neutral
Price Target:EUR 0.36â–¼(-9.60% Downside)
Action:reiterated
Date:10/09/26

The score is held down primarily by persistent losses and worsening cash burn despite improving revenue and gross margin. Technically, the stock remains in a broader downtrend (below major moving averages with negative MACD). Valuation is difficult to support using earnings metrics due to negative profitability and no dividend information.

Positive Factors
Revenue ExpansionThe substantial increase in revenue demonstrates meaningful commercial progress and broader market adoption of Fermentalg’s microalgae-based ingredients. Continued top-line growth can improve operating leverage over time, provided the company converts expanding sales into stronger margins and cash generation.
Negative Factors
Persistent UnprofitabilityFermentalg has not yet scaled its revenue base sufficiently to cover its cost structure, despite improved sales and gross margin. Persistent operating and net losses weaken financial resilience, constrain internally funded investment, and make future performance dependent on achieving a meaningful profitability inflection.

Fermentalg SA (ALGAE) vs. iShares MSCI France ETF (EWQ)

-20%-10%0%10%20%30%40%50%FR:ALGAE-11.21%EWQ+0.40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 46.73M
Dividend Yield
―
Average Volume (3M)
76.87K
Price to Earnings (P/E)
-4.6
Beta (1Y)
0.91
Revenue Growth
3.22%
EPS Growth
24.05%
Country
France
Employees
62
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Fermentalg SA Business Overview & Revenue Model

Company Description

Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various i...

Fermentalg SA Financial Statement Overview

Summary

Revenue growth and gross margin improvement (to ~17% in 2025) are positives, and leverage is relatively conservative (debt-to-equity ~0.20). However, profitability remains very weak with deeply negative margins (net margin ~-71%), equity has declined, and cash burn worsened materially in 2025 (operating cash flow ~-€6.6m; free cash flow ~-€8.1m), keeping the financial risk elevated.

Income Statement

28Negative

Balance Sheet

54Neutral

Cash Flow

24Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue13.20M13.38M11.50M4.06M7.65M5.65M
Gross Profit959.00K2.29M2.50M536.00K-828.00K-675.00K
EBITDA-7.90M-6.32M-9.99M-10.49M-7.19M-8.91M
Net Income-9.31M-9.44M-12.88M-14.15M-9.87M-6.85M
Balance Sheet
Total Assets43.31M36.44M51.14M50.24M57.54M60.88M
Cash, Cash Equivalents and Short-Term Investments10.79M6.62M20.58M11.16M15.90M26.01M
Total Debt3.93M5.02M12.60M15.35M11.02M9.61M
Total Liabilities11.40M11.26M18.39M19.40M15.56M13.87M
Stockholders Equity31.91M25.18M32.76M30.85M41.98M47.00M
Cash Flow
Free Cash Flow-7.69M-8.13M-2.00M-11.18M-13.72M-12.55M
Operating Cash Flow-6.27M-6.59M-531.00K-8.69M-8.24M-7.66M
Investing Cash Flow-938.00K-1.75M-1.13M-1.76M-7.29M-4.75M
Financing Cash Flow5.14M-5.62M11.08M5.71M5.42M26.58M

Fermentalg SA Technical Analysis

Technical Analysis SentimentPositive
Last Price0.40

Price Trends

50DMA0.42Negative
100DMA0.45Negative
200DMA0.47Negative

Market Momentum

MACD-0.01Negative
RSI48.63Neutral
STOCH60.83Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALGAE, the sentiment is Positive. The current price of 0.40 is above the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.42, and below the 200-day MA of 0.47, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 48.63 is Neutral, neither overbought nor oversold. The STOCH value of 60.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALGAE.

Fermentalg SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

FR:ALGAE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:ALPATFR:ALPAT60NeutralEUR 4.52M6.59――10.59%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALGAEFR:ALGAE44NeutralEUR 46.73M-4.56-32.62%―3.22%24.05%
FR:ALVALFR:ALVAL43NeutralEUR 21.64M-2.09-84.11%―183.47%57.15%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%FR:ALGAEFR:ALVALFR:ALPATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:ALGAE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:ALGAEFermentalg SA0.40-0.06-13.91%
FR:ALVALValbiotis SA0.610.0611.82%
FR:ALPATPlant Advanced Technologies SA3.98-4.32-52.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 09, 2026